In clinical trials and drug development, receptor occupancy assays by flow cytometry are increasingly becoming the recommended method to establish efficacy of the targeted drug.
In this on-demand webinar, experienced scientists from Medpace’s central labs discuss how flow cytometric receptor occupancy assays — when correctly implemented — are a powerful tool in modelling pharmacokinetic/pharmacodynamic (PK/PD) relationships in the development of novel drugs.
Topics will include:
- The definition of a receptor occupancy assay
- How to design and implement a receptor occupancy assay in a clinical laboratory
- The benefit of receptor occupancy assays in clinical trials
Medpace has an experienced flow cytometry team overseen by PhD-level scientists with over 10 years of experience designing, analyzing, and interpreting multicolor flow cytometry assays. Learn more about our global flow cytometry capabilities.